Free and total calcium concentrations in the blood of rainbow trout, Salmo gairdneri, during stress conditionsANDREASEN, P.Journal of experimental biology. 1985, Vol 118, pp 111-120, issn 0022-0949Article

Molecular mass of proteins and their partitioning in aqueous two-phase systemsANDREASEN, P. A.Journal of chromatography. 1994, Vol 664, Num 1, pp 99-103, issn 0021-9673Article

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorCUBELLIS, M. V; ANDREASEN, P; RAGNO, P et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 13, pp 4828-4832, issn 0027-8424Article

ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA∼PAI-1 and tPA∼PAI-1)GREBENSCHIKOV, N; SWEEP, F; GEURTS, A et al.International journal of cancer. 1999, Vol 81, Num 4, pp 598-606, issn 0020-7136Article

Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1ZEHAB, R; RAFFERTY, U. M; RODRIGUEZ, M. A et al.Thrombosis and haemostasis. 1987, Vol 58, Num 4, pp 1017-1023, issn 0340-6245Article

Comparison of methods of hazard identification at plant levelANDREASEN, P; RASMUSSEN, B.Journal of loss prevention in the process industries. 1990, Vol 3, Num 4, pp 339-344, issn 0950-4230, 6 p.Article

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancerDUFFY, M. J; REILLY, D; O'SULLIVAN, C et al.Cancer research (Baltimore). 1990, Vol 50, Num 21, pp 6827-6829, issn 0008-5472, 3 p.Article

Interaction of plasminogen activator inhibitor (PAI-1) with vitronectinSALONEN, E.-M; VAHERI, A; STEPHENS, R et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 11, pp 6339-6343, issn 0021-9258Article

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsPOLLANEN, J; SAKSELA, O; SALONEN, E.-M et al.The Journal of cell biology. 1987, Vol 104, Num 4, pp 1085-1096, issn 0021-9525Article

MICHAELIS-MENTEN KINETICS OF PHENAZONE ELIMINATION IN THE PERFUSED PIG LIVER.BUCH ANDREASEN P; TONNESEN K; RABOL A et al.1977; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1977; VOL. 40; NO 1; PP. 1-13; BIBL. 2 P.Article

The political dimension in health care technology assessment programsBANTA, H. D; ANDREASEN, P. B.International journal of technology assessment in health care. 1990, Vol 6, Num 1, pp 115-123, issn 0266-4623Article

Structure and evolution of the Tetrahymena thermophila gene encoding ribosomal protein L21ROSENDAHL, G; ANDREASEN, P. H; KRISTIANSEN, K et al.Gene (Amsterdam). 1991, Vol 98, Num 2, pp 161-167, issn 0378-1119, 7 p.Article

Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitorMUNCH, M; HEEGAARD, C. W; ANDREASEN, P. A et al.Biochimica et biophysica acta. Protein structure and molecular enzymology. 1993, Vol 1202, Num 1, pp 29-37, issn 0167-4838Article

Regulation of ribosome synthesis in Tetrahymena pyriformis. I: Coordination of synthesis of ribosomal proteins and ribosomal RNA during nutritional shift-downDREISIG, H; ANDREASEN, P. H; KRISTIANSEN, K et al.European journal of biochemistry (Print). 1984, Vol 140, Num 3, pp 469-475, issn 0014-2956Article

Regulation of ribosome synthesis in Tetrahymena pyriformis. II: Coordination of synthesis of ribosomal proteins and ribosomal RNA during nutritional shift-upDREISIG, H; ANDREASEN, P. H; KRISTIANSEN, K et al.European journal of biochemistry (Print). 1984, Vol 140, Num 3, pp 477-483, issn 0014-2956Article

Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-βLAIHO, M; SAKSELA, O; ANDREASEN, P. A et al.The Journal of cell biology. 1986, Vol 103, Num 6, pp 2403-2410, issn 0021-9525Article

Lack of interaction between cimetidine and carbamazepineSONNE, J; LÜHDORF, K; LARSEN, N. E et al.Acta neurologica scandinavica. 1983, Vol 68, Num 4, pp 253-256, issn 0001-6314Article

Type-1 inhibitor of plasminogen activators : distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodiesMUNCH, M; HEEGAARD, C; JENSEN, P. H et al.FEBS letters. 1991, Vol 295, Num 1-3, pp 102-106, issn 0014-5793Article

Metronidazole pharmacokinetics in patients with hepatic encephalophathyLOFT, S; SONNE, J; DØSSING, M et al.Scandinavian journal of gastroenterology. 1987, Vol 22, Num 1, pp 117-123, issn 0036-5521Article

Solvent effects on activity and conformation of plasminogen activator inhibitor-1ANDREASEN, P. A; EGELUND, R; JENSEN, S et al.Thrombosis and haemostasis. 1999, Vol 81, Num 3, pp 407-414, issn 0340-6245Article

The urokinase-type plasminogen activator system in cancer metastasis : A reviewANDREASEN, P. A; KJØLLER, L; CHRISTENSEN, L et al.International journal of cancer. 1997, Vol 72, Num 1, pp 1-22, issn 0020-7136Article

Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated ratsANDREASEN, P. A; KRISTENSEN, P; LUND, L. R et al.Endocrinology (Philadelphia). 1990, Vol 126, Num 5, pp 2567-2576, issn 0013-7227Article

Nucleic Acid Aptamers Against Proteases : Aptamers: Versatile Agents for biomedical ApplicationsDUPONT, D. M; ANDERSEN, L. M; BOTKJAER, K. A et al.Current medicinal chemistry. 2011, Vol 18, Num 27, pp 4139-4151, issn 0929-8673, 13 p.Article

A common response element mediates differential effects of phorbol esters and forskolin on type-1 plasminogen activator inhibitor gene expression in human breast carcinoma cellsKNUDSEN, H; OLESEN, T; RICCIO, A et al.European journal of biochemistry (Print). 1994, Vol 220, Num 1, pp 63-74, issn 0014-2956Article

Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiationHANSEN, H. O; ANDREASEN, P. H; MANDRUP, S et al.Biochemical journal (London. 1984). 1991, Vol 277, pp 341-344, issn 0264-6021, 2Article